Conference Coverage

Cancer Vaccine Research Now a Priority

Published in Vaccine Weekly, March 27th, 1995

In a rapid change of direction, cancer researchers at the U.S. National Cancer Institute, biotechnology companies, and academic research institutions are committing extensive resources to the search for therapeutic cancer vaccines.

"Two years ago I said that the 80s were the decade of monoclonal antibodies and that the 90s were the decade of vaccines. That is even more true today," Lynn Spitler, director of the Melanoma Research Institute, San Francisco, California, said in opening remarks to the Second International Conference on Engineered Vaccines for Cancer and AIDS, held March 3-5 in San Francisco, California. "I am astonished with the number of studies, the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry